
MEDISTEP
Medistep Healthcare Limited
- IPO Status
- Closed
- Open Date
- 8 Aug 2025
- Close Date
- 12 Aug 2025
IPO Details
- Min. Investment
- ₹2,58,000
- Price Band
- ₹43
- Lot Size
- 3000 shares
- Issue Size
- ₹16 Cr
- Face Value
- 10
- IPO Doc
- —
Schedule
- IPO open8 Aug 2025
- IPO close date12 Aug 2025
- Allotment date13 Aug 2025
- Funds unblock or debit14 Aug 2025
- Listing date18 Aug 2025
Financial Performance
- Revenue
- Profit
Stocks similar to MEDISTEP
- Fabino Enterprises Limited
- Achyut Healthcare Limited
FAQs
Medistep Healthcare Limited IPO is a SME IPO aggregating up to ₹16 Cr, with equity shares of face value ₹10 each. The shares are proposed to be listed on NSE.
The Medistep Healthcare Limited IPO opened on 8 Aug 2025 and closed on 12 Aug 2025. IPO Period: 8 Aug 2025 – 12 Aug 2025.
The price band for the Medistep Healthcare Limited IPO is ₹43 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 3,000 shares. At the upper price band of ₹43, the minimum investment required is ₹2,58,000.
Particular Details Lot Size 3,000 shares Minimum Application 6,000 shares Price Band ₹43 Minimum Investment ₹2,58,000 Here is the timeline for the Medistep Healthcare Limited IPO:
IPO Event Date IPO Opens 8 Aug 2025 IPO Closes 12 Aug 2025 UPI Mandate Deadline 12 Aug 2025, 5:00 PM Basis of Allotment 13 Aug 2025 Refund Initiation 14 Aug 2025 Shares Credited 14 Aug 2025 Listing Date 18 Aug 2025 The basis of allotment for the Medistep Healthcare Limited IPO is expected to be finalised on 13 Aug 2025. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: Cameo Corporate Services.
The equity shares of Medistep Healthcare Limited are proposed to be listed on NSE. Proposed Listing Date: 18 Aug 2025.
The key financial performance of Medistep Healthcare Limited is:
Financial Year Revenue Profit FY24 ₹31.62 Cr ₹2.91 Cr FY25 ₹49.65 Cr ₹4.14 Cr FY26 ₹70.83 Cr ₹5.98 Cr Revenue CAGR: 49.7% | Profit CAGR: 43.4%. Figures are as disclosed in the company's offer documents.


